Stay updated on CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome
Sign up to get notified when there's something new on the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page.

Latest updates to the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe two screenshots depict the same page content with only minor layout/visual adjustments; no study data or version history details appear to change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedMajor change: version updated to v3.2.0 with a government-operating-status notice; previous version v3.1.0 removed. Interpreted as an update to page status and versioning.SummaryDifference10%

- Check46 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.2%

- Check60 days agoChange DetectedRevision updated to v3.0.2, replacing v3.0.1. The removal of 'Back to Top' is a minor UI change with no impact on core content.SummaryDifference0.6%

- Check67 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.6%

- Check74 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information. This indicates a shift towards a more generalized presentation of location data.SummaryDifference36%

Stay in the know with updates to CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome
Enter your email address, and we'll notify you when there's something new on the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page.